LSTM led partnership awarded £ 1.5 million for NTD drug development

(Liverpool School of Tropical Medicine) An LSTM led partnership has been awarded nearly £ 1.5 million from the Medical Research Council (MRC) for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, by targeting the bacterial symbiont Wolbachia.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news